Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 45Breast Neoplasms 15Leiomyoma 3Cardiovascular Diseases 3Polycystic Ovary Syndrome 2Neoplasms 2Endometrial Neoplasms 2Advanced Breast Cancer 2Stage II Prostate Adenocarcinoma 1Sexual Dysfunctions, Psychological 1Sarcopenia 1Salivary Gland Adenoma, Pleomorphic 1Prostatic Neoplasms, Castration-Resistant 1Prostatectomy 1Prostate Cancer With ≤10 Bone Metastases 1Prostate Cancer Metastatic Disease 1Prostate Cancer Metastatic 1Pelvic Pain 1Oligometastatic Prostate Carcinoma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Metastatic Castration-resistant Prostate Cancer 1Metabolic Syndrome 1Metabolic Diseases 1Kallmann Syndrome 1Inflammatory Breast Neoplasms 1Infertility 1Hypogonadism 1Hyperprolactinemia 1

Interventions

Cabergoline 2ropinirole 1Gonadotropin-Releasing Hormone 1Dopamine Agonists 1Clomiphene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hyperprolactinemia × Gonadotropin-Releasing Hormone × Clear all
NCT00914823 2024-07-31

Kisspeptin Administration in the Adult

Massachusetts General Hospital

Phase 1 Completed
256 enrolled

Hyperprolactinemia, Hypogonadism, Polycystic Ovary Syndrome, Kallmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡